Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Panacea Biotec Ltd

NSE: PANACEABIO · BSE: 531349 · Pharmaceuticals & Biotechnology · 28 announcements

Share price
₹357.10
Market cap
₹2,187 Cr
Revenue (annual)
₹639.8 Cr
Net profit (annual)
₹-5.37 Cr
P/E (TTM)
-307.2×Sector 47.4×
Promoter holding
72.48%+0.00% QoQ
FII holding
2.31%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

15:01 IST BSE
Other Announcement

Panacea Biotec Other Announcement

Panacea Biotec sent reminder letters to physical shareholders requesting PAN and KYC updates per SEBI circulars. No transaction or business event is involved.

17:40 IST NSE
Other Announcement

Panacea Biotec Other Announcement

Panacea Biotec Limited has submitted its monthly share dematerialization report for August 2026. This is a routine regulatory compliance filing under SEBI Regulation 74(5).

16:27 IST BSE
Other Announcement

Panacea Biotec Other Announcement

Panacea Biotec filed its FY2026 Annual Secretarial Compliance Report. The report notes a minor ₹0.02 Crore penalty for a prior dividend intimation delay.

Value
₹0.02 Cr
12:01 IST BSE
Other Announcement

Panacea Biotec Other Announcement

Panacea Biotec Ltd submitted a compliance certificate for the quarter ended March 31, 2026, under SEBI (Depositories and Participants) Regulations. The certificate, issued by Skyline Financial Services, confirms that physical share certificates received for dematerialization were processed, cancelled, and substituted with the depository's name within the mandated 15-day period.

11:57 IST BSE
Other Announcement

Panacea Biotec Other Announcement

Panacea Biotec Ltd reported its monthly dematerialisation status for March 2026. The company confirmed that no shares were dematerialised during the month, with the total demat holding remaining stable at 6,11,04,526 shares across NSDL and CDSL.